Collegium to Participate in Upcoming Investor Conferences
Collegium to Participate in Upcoming Investor Conferences
STOUGHTON, Mass., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in the following investor conferences:
馬薩諸塞州斯托頓,2024年11月12日(GLOBE NEWSWIRE)——致力於改善嚴重疾病患者生活的領先多元化專業製藥公司Collegium Pharmaceutical, Inc.(納斯達克股票代碼:COLL)今天宣佈,管理層將參加以下投資者會議:
Jefferies London Healthcare Conference
Fireside Chat Date and Time: Tuesday, November 19, 2024, at 1:30 p.m. GMT
傑富瑞倫敦醫療保健會議
爐邊聊天日期和時間:格林尼治標準時間 2024 年 11 月 19 日星期二下午 1:30
Piper Sandler 36th Annual Healthcare Conference
Fireside Chat Date and Time: Thursday, December 5, 2024, at 1:00 p.m. ET
派珀·桑德勒第 36 屆年度醫療保健會議
爐邊聊天日期和時間:美國東部時間 2024 年 12 月 5 日星期四下午 1:00
The fireside chats will be webcast live and can be accessed from the Investors section of the Company's website: . A replay of the webcast will be archived on the Company's website for 90 days following the presentation.
爐邊聊天將進行網絡直播,可以從公司網站的 「投資者」 部分進行訪問:.網絡直播的重播將在演示結束後的90天內在公司網站上存檔。
About Collegium Pharmaceutical, Inc.
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium's headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company's website at .
關於 Collegium 製藥公司
Collegium是一家領先的多元化專業製藥公司,致力於改善患有嚴重疾病的人的生活。Collegium 的總部位於馬薩諸塞州的斯托頓。欲了解更多信息,請訪問該公司的網站。
Investor Contact:
Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com
投資者聯繫人:
丹妮爾·傑西
投資者關係董事
ir@collegiumpharma.com
Media Contact:
Marissa Samuels
Vice President, Corporate Communications
communications@collegiumpharma.com
媒體聯繫人:
瑪麗莎·塞繆爾斯
企業傳播副總裁
communications@collegiumpharma.com